🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main purpose of the study is to find out if, after 4 weeks of dosing, s...
Status
Completed
Location
Multiple Locations
Start Date
2007-05
Trial ID
NCT00454298
Treatments Being Tested
The primary purpose of this study is to evaluate the effect of the up-titra...
Status
Completed
Location
SGS Clinical Pharmacology Unit (located in ZNA Stuivenberg)
Start Date
2019-03-20
Trial ID
NCT03882255
Treatments Being Tested
This is a Phase II, randomized, double-blind, placebo-controlled, parallel-...
Status
Completed
Location
Multiple Locations
Start Date
2010-11
Trial ID
NCT01225393
Treatments Being Tested
This study will be conducted to evaluate the efficacy of lecanemab in parti...
Status
Active Not Recruiting
Location
Banner Alzheimer's Institute- Clinical Trials Department
Start Date
2019-03-27
Trial ID
NCT03887455
Treatments Being Tested
This is a 24-week study investigating the safety and efficacy of several do...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-04-28
Trial ID
NCT00111800
Treatments Being Tested
The overall purpose of the trial is to evaluate efficacy and safety of tiot...
Status
Completed
Location
205.456.01004 Boehringer Ingelheim Investigational Site
Start Date
2011-01
Trial ID
NCT01277523
Treatments Being Tested
Part A: The primary objective is to evaluate the safety and tolerability of...
Status
Completed
Location
Biokinetic Europ Ltd
Start Date
2015-05
Trial ID
NCT02459262
Treatments Being Tested
This study is an open label study followed by a randomised, double-blind, p...
Status
Unknown
Location
Centre Georges Grancois Leclerc
Start Date
2022-03-15
Trial ID
NCT05240131
Treatments Being Tested
The objective of this extension study is the initial assessment of safety a...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-03-29
Trial ID
NCT02690181
Treatments Being Tested
This is a Phase 1, double-blind, randomized, repeat-dose, single -dite, 4-a...
Status
Completed
Location
Research Site 1
Start Date
2008-05
Trial ID
NCT00675701
Treatments Being Tested